215433-89-9Relevant articles and documents
FORMULATIONS FOR PHARMACEUTICAL AGENTS IONIZABLE AS FREE ACIDS OR FREE BASES
-
, (2008/06/13)
-
3-(cycloalkanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors
-
Page column 27, (2010/02/05)
The present invention relates to novel 3-(cycloalkano-heteroarylidenyl)-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which are expected to modulate the activity of protein tyrosine kinases and therefore to be useful in the prevention and treatment of protein tyrosine kinase related cellular disorders such as cancer.